Skip to content

Clinical trials

Phase 1/2 Stomach Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1/2 Country / region: Taiwan Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20142
20151
20161
20193
20201
20211
20223
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Terminated4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
AstraZeneca1
BeiGene1
Bolt Biotherapeutics, Inc.1
DualityBio Inc.1
Eli Lilly and Company1
Inhibrx Biosciences, Inc1
Kymab Limited1
MacroGenics1
Mural Oncology, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms15
Carcinoma, Non-Small-Cell Lung7
Squamous Cell Carcinoma of Head and Neck5
Breast Neoplasms4
Esophageal Neoplasms4
Melanoma4
Neoplasms4
Carcinoma, Renal Cell3
Cholangiocarcinoma3
Biliary Tract Neoplasms2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.